Your browser doesn't support javascript.
loading
Sinomenine hydrochloride suppresses the stemness of breast cancer stem cells by inhibiting Wnt signaling pathway through down-regulation of WNT10B.
Li, Xiaomei; Chen, Wei; Huang, Linxi; Zhu, Mengmei; Zhang, Hongxia; Si, Yachen; Li, Hengyu; Luo, Qing; Yu, Bing.
Afiliação
  • Li X; Cancer Research Laboratory, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou Province 563003, PR China; Department of Cell Biology, Center for Stem Cell and Medicine, Naval Medical University (Second Military Medical University), Shanghai 200433, PR China.
  • Chen W; Department of Nephrology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, PR China.
  • Huang L; Department of Nephrology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, PR China.
  • Zhu M; Department of Cell Biology, Center for Stem Cell and Medicine, Naval Medical University (Second Military Medical University), Shanghai 200433, PR China.
  • Zhang H; Department of Cell Biology, Center for Stem Cell and Medicine, Naval Medical University (Second Military Medical University), Shanghai 200433, PR China.
  • Si Y; Department of Nephrology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, PR China.
  • Li H; Department of General Surgery IV, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, PR China. Electronic address: drlhy@foxmail.com.
  • Luo Q; Cancer Research Laboratory, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou Province 563003, PR China. Electronic address: zlsysluoqing@163.com.
  • Yu B; Department of Cell Biology, Center for Stem Cell and Medicine, Naval Medical University (Second Military Medical University), Shanghai 200433, PR China. Electronic address: smmucellyu@163.com.
Pharmacol Res ; 179: 106222, 2022 05.
Article em En | MEDLINE | ID: mdl-35413424
ABSTRACT
Sinomenine hydrochloride (SH) has anti-breast cancer effect, but whether it can act on breast cancer stem cells (BCSCs) is unclear. Here, we explored the effect of SH on BCSCs and its mechanism. We observed that SH decreased the ratio of CD44+/CD24- BCSCs and the expression of BCSCs-related genes in MCF-7 and MDA-MB-231 cells. SH significantly inhibited the stemness of CD44+/CD24- BCSCs, including the capacity of self-renewal, oncosphere formation, migration and invasion, and the expression of stemness-related genes. Furthermore, SH obviously inhibited the expression of Wnt signaling pathway genes in CD44+/CD24- BCSCs, especially the expression of WNT10B and its downstream target genes. While WNT10B was overexpressed, the inhibitory effect of SH on the stemness of BCSCs was blocked, indicating that SH inhibited the stemness of BCSCs by down-regulating WNT10B. When WNT10B was knocked down, the stemness of BCSCs was significantly inhibited, indicating that WNT10B was involved in the stemness maintenance of BCSCs. SH also significantly inhibited the growth of MDA-MB-231 BCSCs xenografts, decreased the expression of BCSCs related genes and suppressed Wnt signaling pathway in vivo. In conclusion, SH negatively regulates the stemness of CD44+/CD24- BCSCs by inhibiting Wnt signaling pathway through down-regulation of WNT10B expression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Via de Sinalização Wnt Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Via de Sinalização Wnt Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article